Nektar Therapeutics - Company Profile

All the data and insights you need on Nektar Therapeutics in one report.

$295

Buy Report View Sample

Save hours of research time and resources with
our up-to-date Nektar Therapeutics Strategy Report
Understand Nektar Therapeutics position in the market,
performance and strategic initiatives.
Gain competitive edge and increase your
chances of success

Nektar Therapeutics: Patents

View up-to-date information on Nektar Therapeutics patents, including inventor and filing insights.

Publication Identifier	Document Type	Title	Classification-CPC	Publication Date
US11419943B2	Grant	Polymer-sunitinib conjugates	A61K31/404; A61K47/58; A61K47/60	August 23, 2022
KR102432169B1	Grant	-15 CONJUGATES OF AN IL-15 MOIETY AND A POLYMER	A61K38/2086; A61K47/00; A61K47/60; A61P35/00; A61P35/04; A61P43/00; C08G65/34; C08G65/48	August 11, 2022
US11406618B2	Grant	Polymer-des-ethyl sunitinib conjugates	A61K31/404; A61K47/60	August 09, 2022
US20220235056A1	Application	ADENOSINE 2 RECEPTOR ANTAGONISTS	C07B2200/05; C07D487/04; C07D519/00	July 28, 2022
NL301184I2	Grant	rurioctocog alfa pegol	A61K38/37; A61K38/38; A61K47/10; A61K47/50; A61K47/60; A61P7/00; A61P7/04; A61P7/06	July 21, 2022

Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Find out more

Name	Count

Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Find out more

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer